1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Contrast Media Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Contrast Media Market Revenue and Volume, by Modality Type
8.1.1. Ultrasound FG
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Magnetic Resonance Imaging
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. X-ray/Computed Tomography
8.1.3.1. Market Revenue and Volume Forecast
9.1. Contrast Media Market Revenue and Volume, by Product
9.1.1. Microbubble
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Gadolinium-Based
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Iodinated
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Barium-Based
9.1.4.1. Market Revenue and Volume Forecast
10.1. Contrast Media Market Revenue and Volume, by Application
10.1.1. Cardiovascular Disorders
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Neurological Disorders
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Gastrointestinal Disorders
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Cancer
10.1.4.1. Market Revenue and Volume Forecast
10.1.5. Nephrological Disorders
10.1.5.1. Market Revenue and Volume Forecast
10.1.6. Musculoskeletal Disorders
10.1.6.1. Market Revenue and Volume Forecast
10.1.7. Others
10.1.7.1. Market Revenue and Volume Forecast
11.1. Contrast Media Market Revenue and Volume, by Application Route of Administration
11.1.1. Intravenous
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Oral Route
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Rectal Route
11.1.3.1. Market Revenue and Volume Forecast
12.1. Contrast Media Market Revenue and Volume, by End Use
12.1.1. Hospitals
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Diagnostic Imaging Centers
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Others
12.1.3.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Modality Type
13.1.2. Market Revenue and Volume Forecast, by Product
13.1.3. Market Revenue and Volume Forecast, by Application
13.1.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.1.5. Market Revenue and Volume Forecast, by End Use
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Modality Type
13.1.6.2. Market Revenue and Volume Forecast, by Product
13.1.6.3. Market Revenue and Volume Forecast, by Application
13.1.6.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.1.6.5. Market Revenue and Volume Forecast, by End Use
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Modality Type
13.1.7.2. Market Revenue and Volume Forecast, by Product
13.1.7.3. Market Revenue and Volume Forecast, by Application
13.1.7.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.1.7.5. Market Revenue and Volume Forecast, by End Use
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Modality Type
13.2.2. Market Revenue and Volume Forecast, by Product
13.2.3. Market Revenue and Volume Forecast, by Application
13.2.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.2.5. Market Revenue and Volume Forecast, by End Use
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Modality Type
13.2.6.2. Market Revenue and Volume Forecast, by Product
13.2.6.3. Market Revenue and Volume Forecast, by Application
13.2.7. Market Revenue and Volume Forecast, by Application Route of Administration
13.2.8. Market Revenue and Volume Forecast, by End Use
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Modality Type
13.2.9.2. Market Revenue and Volume Forecast, by Product
13.2.9.3. Market Revenue and Volume Forecast, by Application
13.2.10. Market Revenue and Volume Forecast, by Application Route of Administration
13.2.11. Market Revenue and Volume Forecast, by End Use
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Modality Type
13.2.12.2. Market Revenue and Volume Forecast, by Product
13.2.12.3. Market Revenue and Volume Forecast, by Application
13.2.12.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.2.13. Market Revenue and Volume Forecast, by End Use
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Modality Type
13.2.14.2. Market Revenue and Volume Forecast, by Product
13.2.14.3. Market Revenue and Volume Forecast, by Application
13.2.14.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.2.15. Market Revenue and Volume Forecast, by End Use
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Modality Type
13.3.2. Market Revenue and Volume Forecast, by Product
13.3.3. Market Revenue and Volume Forecast, by Application
13.3.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.3.5. Market Revenue and Volume Forecast, by End Use
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Modality Type
13.3.6.2. Market Revenue and Volume Forecast, by Product
13.3.6.3. Market Revenue and Volume Forecast, by Application
13.3.6.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.3.7. Market Revenue and Volume Forecast, by End Use
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Modality Type
13.3.8.2. Market Revenue and Volume Forecast, by Product
13.3.8.3. Market Revenue and Volume Forecast, by Application
13.3.8.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.3.9. Market Revenue and Volume Forecast, by End Use
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Modality Type
13.3.10.2. Market Revenue and Volume Forecast, by Product
13.3.10.3. Market Revenue and Volume Forecast, by Application
13.3.10.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.3.10.5. Market Revenue and Volume Forecast, by End Use
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Modality Type
13.3.11.2. Market Revenue and Volume Forecast, by Product
13.3.11.3. Market Revenue and Volume Forecast, by Application
13.3.11.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.3.11.5. Market Revenue and Volume Forecast, by End Use
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Modality Type
13.4.2. Market Revenue and Volume Forecast, by Product
13.4.3. Market Revenue and Volume Forecast, by Application
13.4.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.4.5. Market Revenue and Volume Forecast, by End Use
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Modality Type
13.4.6.2. Market Revenue and Volume Forecast, by Product
13.4.6.3. Market Revenue and Volume Forecast, by Application
13.4.6.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.4.7. Market Revenue and Volume Forecast, by End Use
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Modality Type
13.4.8.2. Market Revenue and Volume Forecast, by Product
13.4.8.3. Market Revenue and Volume Forecast, by Application
13.4.8.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.4.9. Market Revenue and Volume Forecast, by End Use
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Modality Type
13.4.10.2. Market Revenue and Volume Forecast, by Product
13.4.10.3. Market Revenue and Volume Forecast, by Application
13.4.10.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.4.10.5. Market Revenue and Volume Forecast, by End Use
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Modality Type
13.4.11.2. Market Revenue and Volume Forecast, by Product
13.4.11.3. Market Revenue and Volume Forecast, by Application
13.4.11.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.4.11.5. Market Revenue and Volume Forecast, by End Use
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Modality Type
13.5.2. Market Revenue and Volume Forecast, by Product
13.5.3. Market Revenue and Volume Forecast, by Application
13.5.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.5.5. Market Revenue and Volume Forecast, by End Use
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Modality Type
13.5.6.2. Market Revenue and Volume Forecast, by Product
13.5.6.3. Market Revenue and Volume Forecast, by Application
13.5.6.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.5.7. Market Revenue and Volume Forecast, by End Use
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Modality Type
13.5.8.2. Market Revenue and Volume Forecast, by Product
13.5.8.3. Market Revenue and Volume Forecast, by Application
13.5.8.4. Market Revenue and Volume Forecast, by Application Route of Administration
13.5.8.5. Market Revenue and Volume Forecast, by End Use
14.1. GE HealthCare (USA)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Bayer AG (Germany)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Bracco Imaging S.p.A. (Italy)
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Guerbet (France)
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Lantheus Medical Imaging (USA)
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Daiichi Sankyo Company, Ltd. (Japan)
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Fujifilm Holdings Corporation (Japan)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Jiangsu Hengrui Medicine Co., Ltd. (China)
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. J.B. Chemicals & Pharmaceuticals Ltd. (India)
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Fresenius Kabi (Germany)
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client